CELL2SPHERE
LIVE

Serial Number

79205802

Owner

StemTek Therapeutics SL

Attorney

GORDON E.R. TROY

Filing Date

Nov 22, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CELL2SPHERE Trademark

Serial Number: 79205802 • Registration: 5420462

CELL2SPHERE is a trademark filed by StemTek Therapeutics SL on November 22, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

StemTek Therapeutics SL

Kabi 612, Parque Tecnologico de Bizkaia,

Entity Type: 16

Trademark Details

Filing Date

November 22, 2016

Registration Date

March 13, 2018

Published for Opposition

December 26, 2017

Cancellation Date

September 27, 2024

Goods & Services

Chemical preparations for commercial and scientific purposes, other than for medical or veterinary use; biological tissue cultures, cells and cell culture media, other than for medical or veterinary purposes, namely, for scientific and research use; kits for scientific and research use comprised of biological tissue cultures, cells and cell culture media, not for medical or veterinary purposes; chemicals, reagents, biological tissue cultures, cells and cell culture media for use in relation to drug discovery; chemicals, reagents, biological tissue cultures, cells and cell culture media for use in relation to scientific research; kits for scientific and research use comprised primarily of chemical compounds and culture medium for cell culture analysis and also containing plastic laboratory plates

Pharmaceuticals, namely, biological tissue cultures and cell cultures for medical or clinical use; pharmaceuticals for use in the fields of oncology and hepatology; pharmaceuticals for the treatment of cancer and hepatic diseases; medical preparations, namely, biological tissue cultures for medical, veterinary and surgical purposes; diagnostic reagents for pharmaceutical, veterinary and medical use; diagnostic preparations for use in the fields of oncology and hepatology for pharmaceutical, veterinary and medical use; diagnostic preparations for the treatment of cancer and hepatic diseases for pharmaceutical, veterinary and medical use; diagnostic biomarker reagents for medical purposes; enzymes for medical and veterinary purposes; biological tissue cultures, living cells, cell culture media for growing cells and stem cells for medical and veterinary purposes; diagnostic cell cultures for medical and veterinary purposes

Scientific, technological and design services, namely, technical research and design in the field of new pharmaceuticals; scientific research and development; research and development in the field of microorganisms and cells; scientific and technologic services, namely, industrial analysis and research services in the field of biotechnology and pharmaceuticals; scientific research consulting services relating to cell culture research and development in analytical or therapeutic fields; laboratory consulting services relating to the production of artificial biological tissue in analytical or therapeutic fields; scientific research consulting services relating to the use of biological tissue in analytical or therapeutic research fields; contract research services relating to biotechnology; laboratory research in the field of biotechnology and pharmaceuticals; drug discovery services; scientific services, namely, providing laboratory research services relating to the isolation and/or cultivation of human tissues and cells; scientific services, namely, providing laboratory research services relating to the isolation and/or cultivation of human tissues and cells for diagnostic purposes

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Oct 24, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 2, 2025 INTS
INVALIDATION PROCESSED
Oct 2, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 27, 2025 INTR
CANCELLED SECTION 71
Sep 27, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 13, 2023 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 16, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 16, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 16, 2021 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 10, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 26, 2018 FICS
FINAL DISPOSITION PROCESSED
Jun 26, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 13, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 13, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Dec 22, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 6, 2017 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2017 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 6, 2017 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 13, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 10, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 13, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 13, 2017 REAP
REFUSAL PROCESSED BY IB
Jun 3, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 12, 2017 RFCS
REFUSAL PROCESSED BY MPU
May 12, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 8, 2017 RFCR
NON-FINAL ACTION WRITTEN
May 7, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
May 2, 2017 MAFR
ASSIGNED TO EXAMINER
Apr 28, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 20, 2017 REPR